Autologous Endothelial Progenitor Cell CD133
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous Endothelial Progenitor Cell CD133, covering 2013-08-06 to 2013-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis [Phase 1, Phase 2]